Orbimed Advisors, Director: Kinnate Biopharma KNTE Buy · Filed 23/05/02

Trade details

Type: Insider buy
Amount: $589,028.7
Shares · price: 220,610 sh · $2.67 a share
Held after: 4,425,462 sh
Stock: Kinnate Biopharma KNTE
Person: Orbimed AdvisorsDirector
Trade date: 23/05/02
Filed: 23/05/02
Days to filing: 0 days

15 insiders bought this week

Insiders buying this week: 15 insiders
Holding change: +5.2%

Kinnate Biopharma trades, last 26 weeks

What else happened in Kinnate Biopharma around then

Filed or reported within 30 days of the trade day · 23/04/02~23/06/01

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21